43
Views
0
CrossRef citations to date
0
Altmetric
Miscellaneous

COX-2 inhibitors

Pages 1465-1468 | Published online: 02 Mar 2005

Bibliography

  • MASFERRER JL, ZWEIFEL BS, SEIBERT K, NEEDLEMAN P: Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J. Clin. Invest. (1990) 86:1375–1379.
  • MITCHELL JA, AKARASEREENONT P, THIEMERMANN C, FLOWER RJ, VANE JR: Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. Natl. Acad. Sci.USA (1994) 90:11693–11697.
  • •Seminal early paper.
  • CARTY TJ, MARFAT A: Specific COX-2 inhibitors - realizing the promise of safer NSAIDs. Curt: Opin. Investig. Drugs (1999) 1(2):89–96.
  • •Useful review.
  • JACKSON CG Therapeutic potential of COX-2 inhibitors in arthritis. Expert Opin. Investig. Drugs (2001) 10 (7):13171–325.
  • RYN JV, PAIRET M: Selective cyclooxygenase-2 inhibitors: pharmacology, clinical effects and therapeutic potential. Expert Opin. Investig. Drugs (1997) 6 (5):609–614.
  • TALLEY JJ, BROWN DL, CARTER JS et al.: 4- [5-Methy1-3-phenylisoxazol-4-y1]-benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2. J. Med. Chem. (2000) 43(5):775–777.
  • RIENDEAU D, PERCIVAL MD, BRIDEAU C et al.: Etoricwdb (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. ./. Pharmacol. Exp. Ther. (2001) 296(2):558–566.

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.